Pharmaceutical Technology Europe, Mar 1, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Mar 1, 2012
Special Feature
Single-Use Redundant Filtration
By Ranjeet Patil , Michael Felo , George Oulundsen
The authors describe a new assembly for bulk and final drug product filling operations.
Peer-Reviewed Research
Evaluating Impurities in Drugs (Part II of III)
In Part II of a three-part article, the authors examine impurities from chiral molecules, polymorphic contaminants, and genotoxic impurities.
Industry Insider
Stepping Up the Fight Against Counterfeits
By Nathan Jessop
Traditionally more prevalent in less industrialised regions, counterfeit medicines are now more frequently entering the heavily regulated supply chains of EU countries.
Outsourcing Review
CMOs Face a Kodak Moment
The evolving bio/pharmaceutical business model poses risk for CMOs.
Ask the Expert
Parametric release and real-time release testing
By Heribert Häusler
Boehringer Ingelheim's Heribert Häusler tells us about parametric release and real-time testing.
News
News: Market Boom for Generics
By Stephanie Sutton
The pharma industry has reached the long-dreaded patent cliff, but for copycat products, business is booming.
Ingredients
Securing the Pharma Supply Chain
Regulatory bodies, standard-setting organizations, and industry seek to tackle the problem of counterfeit drugs and securing the flow of pharma ingredients.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
20%
Attracting a skilled workforce
28%
Obtaining/maintaining adequate financing
12%
Regulatory compliance
40%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here